CELLFUSE-XTREMITY Trademark
Trademark Overview
On Monday, December 31, 2018, a trademark application was filed for CELLFUSE-XTREMITY with the United States Patent and Trademark Office. The USPTO has given the CELLFUSE-XTREMITY trademark a serial number of 88245683. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, April 1, 2020. This trademark is owned by Regenacell Therapy, Inc.. The CELLFUSE-XTREMITY trademark is filed in the Medical Instrument Products category with the following description:
Medical devices and materials, namely, devices to aspirate bone marrow in the extremities and harvest bone graft and synthetic bone graft substitute materials; Medical device pack consisting of a combination of medical devices and materials, namely, devices to aspirate bone marrow in the extremities and harvest bone graft and synthetic bone graft substitute material
General Information
Serial Number | 88245683 |
Word Mark | CELLFUSE-XTREMITY |
Filing Date | Monday, December 31, 2018 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, April 1, 2020 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Medical devices and materials, namely, devices to aspirate bone marrow in the extremities and harvest bone graft and synthetic bone graft substitute materials; Medical device pack consisting of a combination of medical devices and materials, namely, devices to aspirate bone marrow in the extremities and harvest bone graft and synthetic bone graft substitute material |
Pseudo Mark | CELL FUSE-EXTREMITY |
Classification Information
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, January 22, 2019 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Regenacell Therapy, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Castle Rock, CO 80104 |
Trademark Events
Event Date | Event Description |
Wednesday, April 1, 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Wednesday, April 1, 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, September 11, 2019 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Wednesday, September 11, 2019 | FINAL REFUSAL E-MAILED |
Wednesday, September 11, 2019 | FINAL REFUSAL WRITTEN |
Tuesday, August 20, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, August 19, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, August 19, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, April 25, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, April 25, 2019 | NON-FINAL ACTION E-MAILED |
Thursday, April 25, 2019 | NON-FINAL ACTION WRITTEN |
Wednesday, March 20, 2019 | ASSIGNED TO EXAMINER |
Tuesday, January 22, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, January 3, 2019 | NEW APPLICATION ENTERED IN TRAM |